Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | S-1: General form for registration of securities under the Securities Act of 1933
Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | DEF 14A: Definitive proxy statements
Immune Pharmaceuticals, Inc. | 8-K: Current report
Immune Pharmaceuticals, Inc. | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Immune Pharmaceuticals, Inc. | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
No Data